Save Spravato as a Last-Line Option for Resistant Depression

May 2019

You'll hear buzz about new Rx Spravato (sprah-VAH-toh, esketamine) nasal spray for treating adults with resistant depression.

Some experts already use low-dose IV ketamine infusions in these patients...since growing data suggest this may "jump-start" improvement.

Spravato is the active isomer of ketamine. Both block N-methyl-D-aspartate (NMDA) receptors.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote